They hope to start clinical trials in cystic fibrosis patients in the coming years.
Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation. By means of virtual screening and experiments on mice and human cells in culture, the scientists were able to screen 200,000 compounds and selected two that allowed the causal mutated protein to express itself and fulfill its function. These findings were recently published online in EMBO Molecular Medicine.
Cystic fibrosis is a genetic disorder that affects the epithelia of numerous organs, and particularly those in the lungs, pancreas and intestine. In the lungs, this takes the form of insufficient epithelial hydration, resulting in excess mucus in the bronchi. This mucus retains pathogenic agents and favors the onset of chronic infections and inflammatory conditions that are ultimately fatal to the sufferer.
The disease is caused by mutations in the gene coding for a protein called CFTR (cystic fibrosis transmembrane conductance regulator). This protein, which is essential to ensure the passage of water through an epithelium, is an ion channel that allows chloride ions to pass through cell membranes. To date, about 2,000 gene mutations that cause the disease have been determined, but 70% of cases of cystic fibrosis are due to a single mutation called ?F508. And it is this mutation that is targeted by the recently-discovered compounds.
The scientists used computer techniques to screen 200,000 compounds, looking for those that might interact with a specific zone in the abnormal protein, and found about a dozen potentially active molecules. Using these 12 compounds, they then performed in-vitro tests on human cell cultures and in-vivo experiments on mice showing this mutation. They were thus able to observe that two of these compounds allowed the mutated ?F508-CFTR protein to be trafficked to the membrane and fulfill its role.
The Latest on: Cystic Fibrosis
- Auction aids in the fight against cystic fibrosison November 16, 2019 at 11:15 pm
Lew Dillahunty was honored Saturday, Nov. 9, at the Cystic Fibrosis Foundation's Breath of Life Gala in the William Grant Still Ballroom at Robinson Center, with a crowd of almost 400 looking on. Anne ...
- Life's Greatest Gifts: Breakthrough drug could mean second life for cystic fibrosis patientson November 13, 2019 at 7:33 pm
Others will spend the holiday in the hospital, or stay as hopeful as possible they'll even make it another day. Dan Beach doesn't like to live that way. His cystic fibrosis affects nearly every part ...
- A Bay Area Superhero Fighting Cystic Fibrosison November 13, 2019 at 6:07 am
“Pathway” is a superhero with cystic fibrosis, a genetic disorder that affects the lungs and digestive system. Jeremiah Stemple created the character. He has cystic fibrosis too. “Growing up, I loved ...
- Vertex deal with Wales expands cystic fibrosis treatment coverage to all of UKon November 13, 2019 at 4:55 am
Vertex Pharmaceuticals Inc's drugs for lung condition cystic fibrosis will now be available to patients across the UK after the company reached a pricing deal with Wales on Wednesday.
- Vertex reaches deal with Wales for cystic fibrosis treatmenton November 13, 2019 at 4:18 am
(Reuters) - Vertex Pharmaceuticals Inc said on Wednesday cystic fibrosis patients in Wales would get access to the company’s life-extending drugs following an agreement with the state-funded health ...
- California Boy with Cystic Fibrosis Gets His Wish of Traveling to Paris Grantedon November 12, 2019 at 2:40 pm
A 10-year-old boy with an incurable disease got the surprise of his life when his wish for traveling abroad was granted.
- Study reveals 'bug wars' that take place in cystic fibrosison November 12, 2019 at 11:06 am
Scientists have revealed how common respiratory bugs that cause serious infections in people with cystic fibrosis interact together, according to a new study in eLife. The results provide insights ...
- Navy SEAL for a day, young Cystic Fibrosis patient’s wish grantedon November 12, 2019 at 6:55 am
Andi Valaitis was diagnosed with Cystic Fibrosis at three months old. Her illness didn’t hold her back as a child, but a lung infection she contracted her freshman year of high school sent her health ...
- Vertex Confirms Northern Ireland Offer Accepted for Cystic Fibrosis Medicineson November 12, 2019 at 6:51 am
This means that once the contract is finalized, patients with CF in Northern Ireland ages 2 years and older who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance ...
- ‘It’s like a miracle’: new Cystic Fibrosis drug breathes hope into Utah’s first prescribed patient after just one weekon November 11, 2019 at 9:40 pm
SALT LAKE CITY — A prescription drug, recently approved by the FDA to treat Cystic Fibrosis, is proving to be promising for the state’s first prescribed patient and impact on future generations. On ...
via Google News and Bing News